Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001494650-18-000058)

Filing Details

Accession Number:: 0001494650-18-000058
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-06-11 17:12:27
Reporting Period:: 2018-06-07

Accepted Time:: 2018-06-11 17:12:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1494650	Optinose Inc.	OPTN	Pharmaceutical Preparations (2834)	421771610

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1685002	P Robert O'neil	C/O Optinose, Inc. 1020 Stony Hill Road, Suite 300 Yardley PA 19067		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-06-08	2,000	$22.75	2,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2018-06-07	28,879	$22.50	28,879	$22.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,879		2028-06-06	No	4	A	Direct

Footnotes

The option vests and becomes exercisable over a three-year period commencing on June 7, 2018. Thirty-three percent (33%) of the option vests and becomes exercisable on June 7, 2019, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining two years of the three-year period, subject to continued service with the Issuer.